Copper(II) Complexes with 5-Nitro-2-furoic Acid: Synthesis, Structure, Thermal Properties, and Biological Activity

Reaction of copper(II) acetate with 5-nitro-2-furoic acid (NO 2 -Hfur) and N-donor ligands 2,2'‑bipyridine (bpy) and pyridine (py) has resulted in complexes [Cu(NO 2 -fur) 2 (H 2 O) 2 ]·2H 2 O ( I ), [Cu(NO 2 -fur) 2 (py) 2 (H 2 O)] ( II ), and binuclear [Cu 2 (NO 2 -fur) 4 (bpy) 2 ]·H 2 O ( II...

Full description

Saved in:
Bibliographic Details
Published inRussian journal of inorganic chemistry Vol. 67; no. 10; pp. 1545 - 1556
Main Authors Koshenskova, K. A., Lutsenko, I. A., Nelyubina, Yu. V., Primakov, P. V., Aliev, T. M., Bekker, O. B., Khoroshilov, A. V., Mantrov, S. N., Kiskin, M. A., Eremenko, I. L.
Format Journal Article
LanguageEnglish
Published Moscow Pleiades Publishing 01.10.2022
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Reaction of copper(II) acetate with 5-nitro-2-furoic acid (NO 2 -Hfur) and N-donor ligands 2,2'‑bipyridine (bpy) and pyridine (py) has resulted in complexes [Cu(NO 2 -fur) 2 (H 2 O) 2 ]·2H 2 O ( I ), [Cu(NO 2 -fur) 2 (py) 2 (H 2 O)] ( II ), and binuclear [Cu 2 (NO 2 -fur) 4 (bpy) 2 ]·H 2 O ( III ) whose structure was determined by X‑ray diffraction study. Cation Cu 2+ is in square-planar ( I ) or square-pyramidal ( II , III ) environment and has CN(Cu) = 4 ( I ) or 5 ( II , III ), respectively. Stability of complexes I – III in solid phase has been determined by synchronous thermal analysis, stability in solutions has been studied by electronic absorption spectroscopy. Compounds I and II are thermally stable (>100°С). The presence of nitro group in the complexes causes strong exothermal effects, whose intensity is leveled by donor ligand. The storage of solutions of the compounds in 5% glucose solution and 0.9% NaCl for 2 days according to UV spectroscopy causes no their degradation. Biological activity of complexes I – III was studied in vitro toward non-pathogenic strain M. smegmatis (behaves as a model for M. tuberculosis ); antimicrobial activity of compound II toward a number of Gram-positive and Gram-negative bacteria has been investigated.
ISSN:0036-0236
1531-8613
DOI:10.1134/S003602362270005X